Circular RNA DHX33 promotes malignant behavior in ccRCC by targeting miR-489-3p/MEK1 axis

Jie Wang1,2, Jian-Qiu Zhang1,2, Xiao-Lei Zhao3

  • 1Department of Urology, Ninghai First Hospital, Zhejiang 315600, China.

Aging
|July 28, 2020
PubMed

Insights

A novel circular RNA, circDHX33, promotes clear cell renal cell carcinoma (ccRCC) progression by regulating the miR-489-3p/MEK1 pathway. Targeting circDHX33 may offer a new therapeutic strategy for ccRCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer development.
  • The specific involvement of circRNAs in the progression of clear cell renal cell carcinoma (ccRCC) remains largely unexplored.

Purpose of the Study:

  • To investigate the function and mechanism of a novel circRNA, circDHX33, in ccRCC.
  • To determine if circDHX33 could serve as a potential therapeutic target for ccRCC.

Main Methods:

  • Quantitative real-time PCR to measure circDHX33 expression in ccRCC cell lines and tissues.
  • Cell proliferation and invasion assays.
  • In vivo tumor growth experiments.
  • Mechanistic studies involving microRNA (miRNA) sponging and gene expression analysis.

Main Results:

  • circDHX33 was found to be upregulated in ccRCC cell lines and patient tissues.
  • Higher circDHX33 levels correlated with advanced TNM stage and metastasis in ccRCC patients.
  • Inhibition of circDHX33 suppressed ccRCC cell proliferation, invasion, and tumor growth in vivo.
  • circDHX33 was shown to promote ccRCC progression by sponging miR-489-3p and consequently modulating MEK1 expression.

Conclusions:

  • circDHX33 acts as an oncogenic circRNA in ccRCC progression.
  • The circDHX33/miR-489-3p/MEK1 axis is a key pathway driving ccRCC malignancy.
  • circDHX33 represents a promising novel therapeutic target for ccRCC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.6K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K